Clinical Trials
20 trialsTesting the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
National Cancer Institute (NCI)
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
NRG Oncology
Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
Washington University School of Medicine
A Phase II Prospective, Open-Label, Randomized, Multicenter Study of Kangfu Spray for the Prevention of Radiation-Induced Oral Mucositis in Patients With Oral Malignancies Receiving Intensity-Modulated Radiotherapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
preReDSeL
Centre Hospitalier Universitaire Vaudois
Resection and Defect Repair of Oral Cancer Aided by Mixed Reality Technology
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions
University of Massachusetts, Boston
Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
Vanderbilt-Ingram Cancer Center
BaReTox
Centre Georges Francois Leclerc
Surgery With or Without Neoadjuvant Treatment of SBRT Plus Chemoimmunotherapy in Resectable Locally Advanced Oral and HPV-unrelated Oropharyngeal Squamous Cell Carcinoma
Sun Yat-sen University
NeoCamre-HN
National Medical Research Radiological Centre of the Ministry of Health of Russia
A Community Engagement Approach to Improving Communication With Black Men About Oral and Pharyngeal Cancers
University of Illinois at Chicago
Effectiveness of Hydrogen Water Intervention on Acute Oral Inflammation, Oral Microbiota, and Pain Following Free Flap Reconstruction in Patients With Oral Cancer
Kaohsiung Medical University Chung-Ho Memorial Hospital
AASP
Chang Gung Memorial Hospital
CAPTURE
Sir Mortimer B. Davis - Jewish General Hospital
EDDIS-a1
Petrov, Andrey
Benmelstobart-Anlotinib-Chemo for Neoadjuvant Oral Cancer
Jiangsu Cancer Institute & Hospital
Application and Validation of a Smartphone-based Deep Learning System for Oral Potentially Malignant Disorders and Oral Cancer Screening
National Taiwan University Hospital
qMAP
University Medical Center Groningen
Testing and Comparing the Impacts of Mhealth-Based and Web-Based Education on Oral Cancer
University of Rwanda